Evaluation status available after sign-in
About the journal
Current Drug Safety is a journal published by Bentham Science Publishers in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Bentham Science Publishers
- ISSN
- 1574-8863 · 2212-3911
- Country
- Netherlands
- Access
- Not open access / not declared
- Official website
- http://www.eurekaselect.com/588/journal/current-drug-safety
Index listings
- MEDLINE · 2006-01-01
- PUBMED · 2010-07-02
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 96 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1114
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
51
i10-index
379
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 46%
- ORCID iDs in current deposits
- 59%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101270895
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Drug-Induced Adverse Reactions
- Drug-Induced Adverse Reactions
- Drug-Induced Adverse Reactions
- Pharmaceutical Practices and Patient Outcomes
- Pharmacy and Medical Practices
Show all subjects (75)
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Drug-Induced Hepatotoxicity and Protection
- Schizophrenia research and treatment
- Patient Safety and Medication Errors
- Pharmacological Effects and Toxicity Studies
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical industry and healthcare
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Pharmacogenetics and Drug Metabolism
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Drug-Induced Hepatotoxicity and Protection
- Diabetes Treatment and Management
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Drug-Induced Hepatotoxicity and Protection
- Pharmaceutical studies and practices
- Complementary and Alternative Medicine Studies
- Schizophrenia research and treatment
- Schizophrenia research and treatment
- Cardiac electrophysiology and arrhythmias
- Cardiac electrophysiology and arrhythmias
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Cardiac electrophysiology and arrhythmias
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Poisoning and overdose treatments
- Poisoning and overdose treatments
- Poisoning and overdose treatments
- Contact Dermatitis and Allergies
- Epilepsy research and treatment
- Chemotherapy-related skin toxicity
- Chemotherapy-related skin toxicity
- Cancer Treatment and Pharmacology
- SARS-CoV-2 and COVID-19 Research
- Rheumatoid Arthritis Research and Therapies
- Antibiotic Use and Resistance
- Chemotherapy-related skin toxicity
- COVID-19 Clinical Research Studies
- Bone health and osteoporosis research
- Epilepsy research and treatment
- Pharmaceutical Economics and Policy
- Computational Drug Discovery Methods
- Pharmacological Effects and Toxicity Studies
- SARS-CoV-2 and COVID-19 Research
- Epilepsy research and treatment
- Pharmaceutical Economics and Policy
- SARS-CoV-2 and COVID-19 Research
- Diabetes Management and Research
- Treatment of Major Depression
- Patient Safety and Medication Errors
- Treatment of Major Depression
- Computational Drug Discovery Methods
- Vaccine Coverage and Hesitancy
- Patient Safety and Medication Errors
- Vaccine Coverage and Hesitancy
- Pharmacology and Obesity Treatment
- Pharmacology and Obesity Treatment
- Metabolism, Diabetes, and Cancer
- Metabolism, Diabetes, and Cancer
- Biosimilars and Bioanalytical Methods
- Biosimilars and Bioanalytical Methods
- Psoriasis: Treatment and Pathogenesis
- Psoriasis: Treatment and Pathogenesis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ